Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -2018/19 group results

May 14 (Reuters)- 
          Takara Bio Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           35.84           32.31          36.00        17.13    
               (+10.9 pct)     (+10.0 pct)    (+0.4 pct)    (-1.4 pct) 
  Operating        5.46            3.56           6.20         2.92    
               (+53.7 pct)     (+11.0 pct)    (+13.5 pct)  (+11.2 pct) 
  Recurring        5.67            3.86           6.45         3.00    
               (+46.7 pct)     (+7.9 pct)     (+13.9 pct)  (+12.4 pct) 
  Net
  Net              3.66            2.34           4.25         1.95    
               (+56.6 pct)     (+72.6 pct)    (+16.2 pct)  (+13.3 pct) 
  EPS           30.38 yen       19.39 yen      35.29 yen    16.20 yen  
  Ann Div       7.00 yen        4.50 yen       8.00 yen                
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       7.00 yen        4.50 yen       8.00 yen                
  
  NOTE - Takara Bio Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news